Physician intervention for medication reduction in a nursing home: the polypharmacy outcomes project
- PMID: 21450207
- PMCID: PMC3102122
- DOI: 10.1016/j.jamda.2010.08.013
Physician intervention for medication reduction in a nursing home: the polypharmacy outcomes project
Abstract
Objective: To examine the effects of a medication review project by geriatricians and geriatric medicine fellows on polypharmacy in a teaching nursing home.
Design: Quality improvement intervention study
Setting: Long-term care facility in Honolulu, HI PARTICIPANTS: Seventy-four patients with the Minimum Data Set quality indicator criteria of polypharmacy (9 or more medications).
Intervention: Geriatric medicine fellows and faculty reviewed each patient's medication list, consulted the updated Beers Criteria and Epocrates online drug-drug interaction program, and recommended medication changes to the patients' primary care physicians.
Measurements: Descriptive statistics, including means, standard deviations, and sums of variables were obtained for the number of medications in the following categories: total number, scheduled, pro re nata, high risk, contraindicated, with potential drug-drug interactions, and with no indication.
Results: Of 160 patients residing in a nursing home, 74 were on 9 or more medications. After the intervention, the mean number of medications per patient in the following categories decreased significantly: total number (16.64 to 15.54, P < .001), scheduled (11.3 to 10.99, P < .001), pro re nata (5.33 to 4.56, P < .001), high risk (0.94 to 0.73, P < .001), contraindicated (0.29 to 0.13, P = .004), with potential drug-drug interactions (6.1 to 4.83, P < .001), and with no indication (3.34 to 3.29, P = .045).
Conclusion: Polypharmacy in long-term care is prevalent and can lead to increased adverse effects and potentially inappropriate prescriptions. This study demonstrates an effective geriatrician-led intervention that both reduced polypharmacy and provided core competency training for geriatric medicine fellows.
Copyright © 2011 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Reducing cost by reducing polypharmacy: the polypharmacy outcomes project.J Am Med Dir Assoc. 2012 Nov;13(9):818.e11-5. doi: 10.1016/j.jamda.2012.07.019. Epub 2012 Sep 5. J Am Med Dir Assoc. 2012. PMID: 22959733 Free PMC article.
-
Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Family Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical Trial.JAMA Intern Med. 2020 Feb 1;180(2):181-189. doi: 10.1001/jamainternmed.2019.5096. JAMA Intern Med. 2020. PMID: 31617562 Free PMC article. Clinical Trial.
-
Combining quality improvement and geriatrics training: the nursing home polypharmacy outcomes project.Gerontol Geriatr Educ. 2014;35(4):395-408. doi: 10.1080/02701960.2014.907159. Epub 2014 Jun 5. Gerontol Geriatr Educ. 2014. PMID: 24829040 Free PMC article.
-
The physician's role in nursing home care: an overview.Geriatrics. 1990 Jan;45(1):47-9. Geriatrics. 1990. PMID: 2104817 Review.
-
Polypharmacy: Evaluating Risks and Deprescribing.Am Fam Physician. 2019 Jul 1;100(1):32-38. Am Fam Physician. 2019. PMID: 31259501 Review.
Cited by
-
Polypharmacy in Polish Older Adult Population-A Cross-Sectional Study: Results of the PolSenior Project.Int J Environ Res Public Health. 2022 Jan 18;19(3):1030. doi: 10.3390/ijerph19031030. Int J Environ Res Public Health. 2022. PMID: 35162054 Free PMC article.
-
Expert-based medication reviews to reduce polypharmacy in older patients in primary care: a northern-Italian cluster-randomised controlled trial.BMC Geriatr. 2021 Nov 23;21(1):659. doi: 10.1186/s12877-021-02612-0. BMC Geriatr. 2021. PMID: 34814835 Free PMC article. Review.
-
Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.J Patient Saf. 2020 Sep;16(3S Suppl 1):S23-S35. doi: 10.1097/PTS.0000000000000747. J Patient Saf. 2020. PMID: 32809998 Free PMC article.
-
A nurse practitioner led protocol to address polypharmacy in long-term care.Geriatr Nurs. 2020 Nov-Dec;41(6):956-961. doi: 10.1016/j.gerinurse.2020.07.002. Epub 2020 Jul 24. Geriatr Nurs. 2020. PMID: 32718755 Free PMC article.
-
An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study.Front Pharmacol. 2020 Mar 18;11:326. doi: 10.3389/fphar.2020.00326. eCollection 2020. Front Pharmacol. 2020. PMID: 32265705 Free PMC article.
References
-
- Nguyen JK, Fouts MM, Kotabe SE, Lo E. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother. 2006;4(1):36–41. - PubMed
-
- Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;161:1629–1634. - PubMed
-
- Gill SS, Misiaszek BC, Brymer C. Improving prescribing in the elderly: A study in the long-term care setting. Can J Clin Pharmacol. 2001;8:78–83. - PubMed
-
- Finkers F, Maring JG, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32:469–476. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
